Educational article

Antibiotic targets

Antibiotics can target cell walls, ribosomes, nucleic-acid processes, membranes or folate metabolism. β-Lactams affect wall synthesis, macrolides act on ribosomes, and fluoroquinolones target topoisomerases.…

Overview

Antibiotics can target cell walls, ribosomes, nucleic-acid processes, membranes or folate metabolism. β-Lactams affect wall synthesis, macrolides act on ribosomes, and fluoroquinolones target topoisomerases. Trimethoprim inhibits an enzyme in the folate pathway.

Biology and practical meaning

Target access and target changes influence activity. Broad spectrum does not mean every bacterium is covered. Bactericidal and bacteriostatic descriptions depend on organism, concentration and conditions rather than automatically establishing clinical superiority. Agents directed at bacterial targets do not treat the viral infection itself.

Targets and example classes
TargetExamples
Peptidoglycanβ-Lactams; glycopeptides act on precursors.
RibosomeAminoglycosides, macrolides, tetracyclines.
TopoisomerasesFluoroquinolones.
Folate metabolismSulfonamides and trimethoprim.
MembranePolymyxins: selected Gram-negative bacteria.

Spectrum, exposure and AST

Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.

Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.

S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.

Sources

Read next

Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.

Open interactive reader